Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. C.T. (Kristel) Muijs


Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

Clinical 3D/4D cumulative proton dose assessment methods for thoracic tumours with large motion

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts

External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapy

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe

Diaphragm-Based Position Verification to Improve Daily Target Dose Coverage in Proton and Photon Radiation Therapy Treatment of Distal Esophageal Cancer

External validation of a prediction model for two-year mortality in esophageal cancer cohorts

First clinical experiences in treating oesophageal cancer with intensity-modulated proton therapy

Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study

Locoregional Residual Esophageal Cancer after Neo-adjuvant Chemoradiotherapy and Surgery Regarding Anatomic Site and Radiation Target Fields A Histopathologic Evaluation Study: A Histopathologic Evaluation Study

Read more